Case Study: a Dutch-based biotechnology company achieves successful USDMF submission with FREYR

Dutch-based Biotechnology Company completes USDMF submission on time with FREYR

Freyr provided regulatory support to a Dutch-based biotechnology company that needed to prepare, review, and submit a US Drug Master File (USDMF) to the FDA. The client faced challenges with FDA requirements and eCTD formatting, which created documentation gaps and risked compliance and approval delays.

Freyr conducted a gap analysis and prepared the necessary DMF modules in eCTD format per FDA guidelines. They incorporated client feedback promptly and finalized the submission. Freyr's work enabled a successful and timely USDMF submission, minimizing compliance risks and optimizing the client's resources.